Form 8-K - Current report:
SEC Accession No. 0001193125-16-423501
Filing Date
2016-01-07
Accepted
2016-01-07 16:10:54
Documents
1
Period of Report
2016-01-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d107976d8k.htm 8-K 13590
  Complete submission text file 0001193125-16-423501.txt   14772
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 161330376
SIC: 2835 In Vitro & In Vivo Diagnostic Substances